Download Citation
Article Source:
RETRACTED: Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis
Hasan R,
Chugaeva UY,
Mohammadian M,
Zamanifard S,
Mohammadian-Hafshejani A
(2025)
RETRACTED: Cardiovascular and mortality outcomes of DPP-4 inhibitors vs. sulfonylureas as metformin add-on therapy in patients with type 2 diabetes: A systematic review and meta-analysis.
PLOS ONE 20(5): e0321032.
https://doi.org/10.1371/journal.pone.0321032